Formulation and Evaluation of Flurbiprofen Loaded Microsponges in Capsule for Sustained Drug Delivery

¹Vaagdevi Institute of Pharmaceutical Science, Bollikunta, Warangal, Telangana, India

²Vikas college of Pharmacy, Jangaon, Telangana, India

³Jyothishmathi Institute of Pharmaceutical Sciences, Karimnagar, Telangana, India

*Corresponding Author: Naresh Kshirasagar, Vaagdevi Institute of Pharmaceutical Science, Bollikunta, Warangal, Telangana, India; Tel: 9676354445; Email: [email protected]

Received Date: 17 February 2023

Published Date: 04 April 2023

Citation: Kshirasagar N, et al. (2023). Formulation and Evaluation of Flurbiprofen Loaded Microsponges in Capsule for Sustained Drug Delivery. Mathews J Pharma Sci.  7(1):16.

Copyrights:  Kshirasagar N, et al. © (2023). 

ABSTRACT

The new investigation in this present work is to develop microsponges constructed novel drug delivery system for sustained action of Flurbiprofen. Various techniques are involved, among them, Quai-emulsion solvent diffusion method was engaged using Ethyl cellulose with different drug: polymer ratio for development of microsponges, for optimization purposes, several factors are considered in investigation. Several evaluation studies for the formed microsponges were carried out FT-IR, SEM, particle size analysis, morphology, encapsulation efficiency and in vitro drug release studies were carried out. Finally, it was concluded that there is no drug polymer interaction as per FT-IR. Encapsulation efficiency, particle size and drug content showed higher impact on alteration of drug polymer ratio. SEM studies showed that morphological microsponges are spherical and porous in nature and with mean particle size of 30.11 ± 0.14 μm. The capsule loaded with microsponges, were followed by In vitro drug release studies and found to release the drug for sustained manner that is 98.12 ±0.63 % of release upto 12 hrs.

Keywords: Microsponges, Flurbiprofen, Capsule, Sustained action

INTRODUCTION

In the current years, the development of new drugs is not sufficient for drug treatment. However, it also involves developing a suitable drug delivery system at the site of action. The in-vivo fate of the drug is not only determined by the properties of the drug but it is also determined by the carrier system, which permits a sustained and localized release of the active drug according to the specific need of the therapy. The biggest challenge up to date is to sustain the delivery of the medicaments by various modern technologies met by extensive research.

Carrier technology is the potential solution to these challenges. Microparticles and nanoparticles have been increasingly researched to achieve targeted and sustained release of drugs. These include microspheres, liposomes, and nanoparticles etc. Which alters the absorption and release characteristics of the drug from these carriers are unable to sustain the release rate of drug from itself. Once the outer wall is ruptured the drug contained within microspheres will be released from it. The microsponges-based polymeric microspheres uniquely overcome problems associate with above technologies. Microsponges are extremely small, inert, indestructible spheres that do not pass through the skin. Rather, they collect in the tiny nooks and crannies of the skin and slowly release the entrapped drug, as the skin needs it. They are designed to deliver a pharmaceutical active ingredient efficiently at the minimum dose, enhance stability, reduce side effects, and modify drug release.

These products are typically presented to the consumer in conventional forms like creams, gels or lotions and they contain a relatively high concentration of active ingredients. Recently their use is also being investigated for oral drug delivery. This article provides concise information to the various aspects of the structure, development, applications and future of microsponges. Oral route has been the commonly adopted and most convenient route for the drug delivery. Oral route of administration has been received more attention in the pharmaceutical field because of the more flexibility in the designing of dosage form than drug delivery design for the other routes.

MATERIAL AND METHODS

Flurbiprofen was obtained as a gift sample from AET Laboratories Pvt., Ltd. Hyderabad. Ethyl cellulose, Poly vinyl alcohol (PVA) were purchase from S.D fine chemical Pvt., Ltd. Mumbai. Alcohol and Dichloro methane (DCM) were purchased from S.D fine chemical Pvt., Ltd., and Mumbai. All other reagents and solvent used are of analytical grade.

PREFORMULATION STUDIES

Determination of Melting point

The melting point of pure drug (FBD) was determined by melting point apparatus (Bio Technics India). The drug was placed in a capillary tube which is sealed one end and opens other end, then the capillary tube was fitted into the holder containing coil, gradually temperature was increased and identified for melting point of pure drug. Average of three readings was taken and compared with standard melting point of drug.

Determination of λ_max : Spectral scanning was done for drug with 10 μg/ml concentration, the maximum absorbance was observed at 248 nm.

Standard curve for Flurbiprofen: 10 mg of Flurbiprofen was weighed and transferred to 100 ml of a volumetric flask the drug was dissolved in 2 ml DMSO and the volume was made up to 100 ml using phosphate buffer pH 6.8 to obtain a stock solution of 100 μg/ml (stock solution), one ml of this stock solution was again diluted with phosphate buffer pH 6.8 up to 10 ml to obtain a solution of 10 μg/ml (stock solution ii). from stock solution ii of 2, 4, 6, 8, 10 ml were transferred to a series of 10 ml volumetric flasks. the volume was made up of phosphate buffer pH 6.8. the absorbances of these solutions were measured at 248 nm against blank.

Solubility Studies of Flurbiprofen

The solubility studies of Flurbiprofen in distilled water, methanol, and phosphate buffer solution pH 6.4 was determined by phase equilibrium method. All excess amount of drug was taken into 20 ml vials containing 10 ml of distilled water, methanol and phosphate buffer pH 6.4. Vials were closed with rubber caps and constantly agitated at room temperature for 24 hrs. using rotary shaker. After 2 hrs. the solution was filtered through 0.2 μm Whatman’s filter paper. The amount of drug solubilized was then estimated by measuring the absorbance at 248 nm using UV-Vis spectrophotometer.

Drug-excipient compatibility study: The drug and excipients selected for the formulation are evaluated for chemical compatibility studies.

Chemical Compatibility study: Infrared spectroscopy was conducted using FT-IR spectrophotometer and the spectrum was recorded in the wave number region of 4000 to 400 cm^-1 the procedure consisted of dispersing the sample (drug alone, mixture of drug and excipients) in potassium bromide and compressed into discs by applying a pressure of 5 tons for 5 minutes in a hydraulic press, the pellet was placed in the light path and the spectrum was recorded.

FORMULATION OF FLURBIPROFEN MICROSPONGES

Flurbiprofen microsponges were prepared by using Quasi emulsion solvent diffusion technique with polymer like ethyl cellulose at different drug to polymer ratios.

Procedure to Formulate Microsponges

Internal phase: Polymer Ethyl Cellulose (EC) was dissolved in 5 ml of dichloromethane and alcohol followed by addition of Flurbiprofen and mixed well until it gets dissolved completely to which triethyl citrate was added as a plasticizer.

External phase: Accurately weighed PVA is added to distilled water to form clear solution. The internal phase was added to external phase drop by drop stirring upto 3 hours at room temperature. The mixture was filtered to separate microsponges and were dried in a desiccator and stored for subsequent investigation.

Table 1: Composition of Flurbiprofen microsponges.

EVALUATION OF PREPARED MICROSPONGES

Production Yield

Percentage yield can be determined by calculating the initial weight of raw materials and the finally obtained weight of microsponges. Percentage yield can be calculated by using the formula:

Actual drug content and theoretical drug content

Samples of all formulated microsponges weighted quantity equivalent to 100 mg of microsponges containing drug were dissolved in 10 ml of phosphate buffer pH 6.4 under sonication for 20min at 25°C followed by membranes filtration of pore size of 0.25 μm and evaluated for drug content spectrophotometrically at 248 nm the actual drug content and encapsulation efficiency were calculated as given formula below (Riyaz et al., 2015).

Actual drug content (%) = [M actual drug / M obtained] × 100

Encapsulation Efficiency

The microsponges was determined spectrophotometrically (λ_max = 248 nm). A sample of FBP microsponges (100 mg) was dissolved in 100 ml of phosphate buffer (pH 6.8) and kept for overnight. The drug content was determined and expressed as actual drug content in microsponges. The encapsulation efficiency (%) of the microsponges was calculated according to the following equation.

Particle size Analysis

Determination of the average particle size of Flurbiprofen loaded microsponges was determined with a binocular microscope using a calibrated ocular and stage micrometer. A minute quantity of microsponges was spread on a clean glass slide with a drop of liquid paraffin and a cover slip is placed on it. The average particle size was calculated by measuring 100 particles of each batch.

cf = SMD/EMD X 10 µm

Particle size = EMD division X cf

Where, SMD = stage microscopic division, EMD = Eye piece microscopic division, cf = correction factor.

Surface Morphology

Scanning Electron Microscopy of microsponges formulation was carried to determine the surface morphology. The sample was mounted directly onto the SEM sample holder using double sided sticking tape and images were recorded at different magnifications at acceleration voltage of 10 kv using scanning electron microscope.

EVALUATION OF FLOW PROPERTIES OF MICROSPONGES

The flow properties of powders are critical for an efficient capsule filling operation. A good flow of the powder or granules is necessary to assure efficient mixing and acceptable weight uniformity for the filling into capsules. The flow property measurements include bulk density, tapped density, angle of repose, compressibility index and Hausner’s ratio. The flow property measurements of microsponges are determined.

Bulk Density (ρ_b)

It is the ratio of total mass of powder to the bulk volume of powder. It was measured by pouring the weighed powder into a measuring cylinder and initial weight was noted. This initial volume was called the bulk volume. From this the bulk density was calculated according to the formula mentioned below. It is expressed in g/cc and is given by

ρ_b = M/ V_b

Where, M and V_b are mass of powder and bulk volume of the powder respectively.

Tapped Density(ρ_t)

It is the ratio of weight of the powder to the tapped volume of powder. The powder was introduced into a measuring cylinder with the aid of funnel and tapped for 500 times on a wooden surface at a 2 sec interval and the volume attained is the tapped volume.

ρ_t = M / V_t

Where, M and V_t are mass and tapped volume of the powder respectively. It is expressed in g/cc.

Angle of Repose (θ)

The flow properties were characterized in terms of angle of repose, Carr’s index and Hausner’s ratio. For determination of angle of repose (θ), the drug and the blend were poured through the walls of a funnel, which was fixed at a position such that its lower tip was at a height of exactly 2.0 cm above hard surface. The drug or the blends were poured till the time when upper tip of the pile surface touched the lower tip of the funnel. Angle of repose was calculated using following equation.

θ = tan^-1 (h/r)

Where, h = height of pile in cm; r = radius of pile in cm.

Carr’s Index (OR) % Compressibility Index

It indicates powder flow properties. It is measured for determining the relative importance of interparticle interactions. It is expressed in percentage and is given by

Where, ρ_t and ρ_b are tapped density and bulk density respectively.

Hausner’s Ratio

Hausner’s ratio is an indirect index of ease of powder flow. It is calculated by the following formula.

HR = ρ_t / ρ_b

Where, ρ_t and ρ_b are tapped density and bulk density respectively.

PREPARATION OF MICROSPONGES FILLED CAPSULES

The optimized microsponges were filled into “1” size capsule each containing 100 mg equivalent of Flurbiprofen.

Table 2: Composition of Flurbiprofen microsponge capsules.

EVALUATION OF MICRSPONGES FILLED CAPSULES

Uniformity of Weight

Intact capsule was weighed. The capsule was opened without losing any part of the shell and contents were removed as completely as possible. The shell was washed with ether or other suitable solvent and the shell allowed to stand until the odor of the solvent was no longer detectable. The empty shell was weighed the procedure was repeated with a further 19 capsules. The average weight was determined. Not more than two of the individual weights deviate from the average weight by more than the percentage deviation shown in table 3 and none deviates by more than twice that percentage.

Table 3: Uniformity of weight.

Disintegration Test

This test determines whether capsules disintegrate within a prescribed time when placed in a liquid medium under the prescribed experimental conditions. A capsule was placed in each of the six tubes of the apparatus and one disc was added to each tube. The time in minutes taken for complete disintegration of the capsule with no palpable mass remaining in the apparatus was measured.

Drug Content

Five capsules were selected randomly and the average weight was calculated. The powder is removed completely and equivalent amount of powder is made up to 100ml with phosphate buffer pH 6.8. 10ml of solution is diluted to 100ml using phosphate buffer pH 6.8 in separate standard flask. The absorbance of solution was recorded at 248 nm.

In Vitro Drug Release

In-vitro release studies of microsponges were carried out by filling equivalent amount of microsponge along with lubricant in capsules and placed in the basket containing phosphate buffer pH 6.8 was used as medium and rotated at 50 rpm. Samples was withdrawn and determined by spectrophotometrically at 248 nm.

In-vitro Anti-Inflammatory Test

1 ml of sample solution was withdrawn during In-vitro drug release study at every one-hour interval, thereafter subjected to in-vitro anti-inflammatory analysis. For the purpose of control, equal volume of distilled water was used. To each reaction mixture, 1 ml of bovine albumin (1% in distilled water) was transferred and pH was adjusted to 6.3 by using small amount of 0.1 N HCl. Samples were incubated for 30 min at 37^°C in the dark followed by incubation at 57 ⁰C for 5 min. Reaction tubes were then cooled under running tap water and turbidity of all the samples were recorded spectrophotometrically at 660 nm.   

Percentage inhibition of albumin denaturation was calculated by using

RELEASE KINETIC STUDIES

The mechanism of drug release from the microsponges filled capsules was studied by fitting the dissolution data of optimized formulation in following models:

Zero order: M=